Published 13:51 IST, September 10th 2020
COVID-19 vaccine: Bharat Biotech's COVAXIN begins Phase 2 of human trials at PGI Rohtak
The phase 2 of the human clinical trial of Bharat Biotech's COVAXIN, India’s first indigenously developed vaccine against COVID-19, began at PGIMS Rohtak
null | Image:
self
Advertisement
13:51 IST, September 10th 2020